J. He, F. Seela / Tetrahedron 58 12002) 4535±4542
4541
*m, OH±C*50)); 5.31 *d, J4.3 Hz, OH±C*30)); 6.56 *t,
J6.4 Hz, H±C*10)); 10.49, 10.60 *2s, NHCO). Anal.
calcd for C21H28N6O5 *444.39): C 56.76, H 6.31, N 18.92;
found: C 56.66, H 6.46, N 18.82.
4. Fidanza, J. A.; McGall, G. H. Nucleosides Nucleotides 1999,
18, 1293±1295.
5. Bailly, C.; Payet, D.; Travers, A. A.; Waring, M. J. Proc. Natl
Acad. Sci. USA 1996, 93, 13623±13628.
6. Chollet, A.; Kawashima, E. Nucleic Acids Res. 1988, 16, 305±
317.
4.1.3. 1-[2-Deoxy-5-O-*4,40-dimethoxytriphenylmethyl)-
b-d-erythro-pentofuranosyl]-4,6-diisobutyrylamino-3-
propynyl-1H-pyrazolo[3,4-d]pyrimidine *8). Compound
7 *0.42 g, 0.94 mmol) was co-evaporated with anhydrous
pyridine *three times) and then dissolved in pyridine
*1.5 ml). To this solution DMT-Cl *0.48g, 1.41 mmol)
was added, and the mixture was stirred at room temperature
for 3 h. The reaction was quenched by addition of MeOH,
and the mixture was evaporated to dryness. It was dissolved
in CH2Cl2 *5 ml) and subjected to FC *CH2Cl2/MeOH 20:1)
to give a colorless foam *0.6 g, 85%). Rf *CH2Cl2/MeOH
9:1) 0.7. UV *MeOH): lmax 237 *48,800), 282 *13,100). 1H
NMR **D6)DMSO), 1.15 *m, CH*CH3)2); 2.07 *s, CH3);
2.30, 2.77 *2m, H2±C*20)); 2.85±3.06 *m, CH*CH3)2,
H2±C*50)); 3.71 *s, CH3O); 3.93 *m, H±C*40)); 4.49 *m,
H±C*30)); 5.34 *d, J4.7 Hz, OH±C*30)); 6.57 *m,
H±C*10)); 6.75±7.33 *m, arom. H); 10.45, 10.63 *s,
NHCO). Anal. calcd for C42H46N6O7 *746.23): C 67.56, H
6.17, N 11.26; found: C 67.64, H 6.30, N 10.96.
7. Szekeres, M.; Matveyev, A. V. FEBS Lett. 1987, 222, 89±94.
8. Gryaznov, S.; Schultz, R. G. Tetrahedron Lett. 1994, 35,
2489±2492.
9. Hoheisel, J. D.; Lehrach, H. FEBS Lett. 1990, 274, 103±106.
10. Haaima, G.; Hansen, H. F.; Christensen, L.; Dahl, O.; Nielsen,
P. E. Nucleic Acids Res. 1997, 25, 4639±4643.
11. Chazin, W. J.; Rance, M.; Chollet, A.; Leupin, W. Nucleic
Acids Res. 1991, 19, 5507±5513.
12. Borah, B.; Cohen, J. S.; Howard, F. B.; Miles, H. T. Bio-
chemistry 1985, 24, 7456±7462.
13. Boudou, V.; Kerremans, L.; De Bouvere, B.; Lescrinier, E.;
Schepers, G.; Busson, R.; Van Aerschot, A.; Herdewijn, P.
Nucleic Acids Res. 1999, 27, 1450±1456.
14. Kirnos, M. D.; Khudyakov, I. Y.; Alexandrushkina, N. I.;
Vanyushin, B. F. Nature 1977, 270, 369±370.
15. Cheong, C.; Tinoco Jr, I.; Chollet, A. Nucleic Acids Res. 1988,
16, 5115±5122.
 ÂÏ Â
16. Sagi, J.; Szakonyi, E.; Vorlõckova, M.; Kypr, J. J. Biomol.
Struct. Dyn. 1996, 13, 1035±1041.
17. Gaffney, B. L.; Marky, L. A.; Jones, R. A. Tetrahedron 1984,
40, 3±13.
4.1.4. 1-[2-Deoxy-5-O-*4,40-dimethoxytriphenylmethyl)-
b-d-erythro-pentofuranosyl]-4,6-diisobutyrylamino-3-
propynyl-1H-pyrazolo[3,4-d]pyrimidine 30-[*2-cyano-
ethyl)-N,N-diisopropylphosphoramidite *9). Compound
8 *0.57 g, 0.76 mmol) dissolved in anhydrous CH2Cl2
*20 ml) under Ar atmosphere was reacted with the
2-cyanoethyl diisopropylphosphoramidochloridite *0.56 ml,
2.4 mmol) in the presence of *iPr)2NEt *0.56 ml, 0.56
mmol) at room temperature. An hour later, the reaction
mixture was diluted with CH2Cl2, and the solution was
washed twice with a 5% aq. NaHCO3 solution, followed
by brine. The organic solution was dried *Na2SO4), concen-
trated, and the residue was submitted to FC *CH2Cl2/acetone
85:15) yielding a colorless foam *0.45 g, 64.7%). Rf *E):
18. Waring, M. J.; Bailly, C. J. Mol. Recognit. 1997, 10, 121±127.
19. Taboury, J. A.; Adam, S.; Taillandier, E.; Neumann, J. M.;
Tran-Dinh, S.; Huynh-Dinh, T.; Langlois d'Estaintot, B.;
Conti, M.; Igolen, J. Nucleic Acids Res. 1984, 12, 6291±6305.
ÂÏ
Â
Â
20. Vorlõckova, M.; Sagi, J.; Szabolcs, A.; Szemzo, A.; Otvos, L.;
Kypr, J. J. Biomol. Struct. Dyn. 1988, 6, 503±510.
21. Seela, F.; Becher, G. Nucleic Acids Res. 2001, 29, 2069±2078.
22. Becher, G.; He, J.; Seela, F. Helv. Chim. Acta 2001, 84, 1048±
1065.
23. Okamoto, A.; Tanaka, K.; Saito, I. Bioorg. Med. Chem. Lett.
2002, 12, 97±99.
24. Seela, F.; Becher, G. Helv. Chim. Acta 2000, 83, 928±942.
25. Seela, F.; Becher, G. Helv. Chim. Acta 1999, 82, 1640±1655.
26. Seela, F.; Becher, G.; Zulauf, M. Nucleosides Nucleotides
1999, 18, 1399±1400.
1
0.44, 0.52. 31P NMR *CDCl3): 149.77, 149.84. H NMR
**D6)DMSO), 1.29 *m, CH*CH3)2); 2.24 *s, CH3);
2.49, 2.69 *2m, H2±C*20)); 3.05±3.80 *m, CH*CH3)2;
H2±C*50)); 3.79 *s, CH3O); 4.23 *m, H±C*40)); 4.82 *m,
H±C*30)); 6.69 *m, H±C*10)); 6.75±7.42 *m, arom. H);
8.27, 8.65 *2s, NHCO).
27. Buhr, C. A.; Wagner, R. W.; Grant, D.; Froehler, B. C. Nucleic
Acids Res. 1996, 24, 2974±2980.
28. Graham, D.; Parkinson, J. A.; Brown, T. J. Chem. Soc., Perkin
Trans. 1 1998, 1131±1138.
29. Ti, G. S.; Gaffney, B. L.; Jones, R. A. J. Am. Chem. Soc. 1982,
104, 1316±1319.
Acknowledgements
30. Muraoka, M.; Miles, H. T.; Howard, F. B. Biochemistry 1980,
19, 2429±2439.
We thank Ms E. Feiling for the synthesis of oligonucleo-
tides. Financial support by the Deutsche Forschungsge-
meinschaft and the Roche Diagnostics GmbH is gratefully
acknowledged.
31. Balow, G.; Mohan, V.; Lesnik, E. A.; Johnston, J. F.; Monia,
B. P.; Acevedo, O. L. Nucleic Acids Res. 1998, 26, 3350±
3357.
32. Seela, F.; Zulauf, M. J. Chem. Soc., Perkin Trans. 1 1999,
479±488.
References
33. Seela, F.; Zulauf, M. Chem. Eur. J. 1998, 4, 1781±1790.
34. Chollet, A.; Chollet-Damerius, A.; Kawashima, E. H. Chem.
Scripta 1986, 26, 37±40.
1. Bailly, C.; Waring, M. J. Nucleic Acids Res. 1998, 26, 4309±
4314.
35. Cano, A.; Goodman, M. F.; Eritja, R. Nucleosides Nucleotides
1994, 13, 501±509.
2. Lamm, G. M.; Blencowe, B. J.; Sproat, B. S.; Iribarren, A. M.;
Ryder, U.; Lamond, A. I. Nucleic Acids Res. 1991, 19, 3193±
3198.
36. Sanghvi, Y. S.; Hoke, G. D.; Freier, S. M.; Zounes, M. C.;
Gonzalez, C.; Cummins, L.; Sasmor, H.; Cook, P. D. Nucleic
Acids Res. 1993, 21, 3197±3203.
3. Howard, F. B.; Miles, H. T. Biopolymers 1983, 22, 597±600.